🔎 Trials Near Me

Hjem › Aterosklerose › Texas › Houston

Aterosklerose kliniske forsøg i Houston, TX

10 studier for Aterosklerose søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RekruttererFase 2
  • Cardiovascular Specialists of Willowbrook, Houston
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

RekruttererFase 2
  • East Texas Cardiology PA, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

RekruttererFase 3
  • Center for Cardiometabolic Disease Prevention/Baylor College of Medicine, Houston
  • Orion Medical - Houston, Houston
  • Research Physicians Network, LLC, Houston
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • og 2 flere
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

RekruttererFase 2/3
  • Clinical Research Strategies, Houston
  • DaVita Clinical Research, Houston
  • Aqua Research Institute, Houston
  • og 4 flere
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

RekruttererFase 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
  • og 4 flere
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

RekruttererFase 3
  • Kelsey Seybold Research Foundation, Houston
Alder 18 til 80 · Alle køn · Opdateret 7. aug. 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

RekruttererFase 3
  • Angiocardiac Care of Texas PA, Houston
  • Dallas Heart and Vascular Consultants PA, Houston
  • Dallas Heart and Vascular Consultants PA, Houston
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

RekruttererFase 4
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Alder 18 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT02915198

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

RekruttererFase 2
  • UT Health Houston, Houston
Alder 40 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT05488431

Aterosklerose forsøg i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.